Core Viewpoint - The company has established the 4th Employee Stock Ownership Plan (ESOP) to enhance employee engagement, attract talent, and align the interests of employees, shareholders, and the company for long-term development [1][2][3]. Summary by Sections General Principles - The ESOP aims to motivate participants, create a shared interest between employees and shareholders, and improve corporate governance [2][3]. - The plan adheres to legal compliance, voluntary participation, risk-bearing by participants, and selective involvement of employees [2][3]. Plan Structure - The total number of shares under the ESOP is capped at 2.894406 million shares, representing 1% of the company's total shares for any single participant [4][5]. - The plan is limited to key personnel in the oncology division, excluding directors, supervisors, and senior management [4][5]. Funding and Stock Source - Funding for the ESOP comes from employees' legal salaries and self-raised funds, with no financial assistance from the company [5][6]. - Shares for the ESOP will be sourced from the company's repurchased shares, with a maximum of 2.894406 million shares available for transfer [5][6]. Pricing and Incentives - The purchase price for the shares is set at 4.38 yuan per share, based on a calculated method considering market conditions [7][8]. - The pricing strategy aims to encourage employee participation while ensuring alignment with company performance and shareholder interests [7][8]. Duration and Lock-up Period - The ESOP has a duration of 72 months, with a lock-up period of 12 months before shares can be gradually unlocked [8][9]. - The unlocking schedule allows for 20% of shares to be released at specified intervals, promoting long-term commitment from participants [8][9]. Management and Governance - The ESOP is managed by a committee elected by participants, ensuring that the interests of all stakeholders are represented [12][15]. - The board of directors is responsible for drafting and modifying the ESOP, with oversight from the supervisory board [12][15]. Rights and Obligations of Participants - Participants must pay their subscription fees on time and are subject to performance evaluations that affect their share unlocks [13][19]. - Participants are prohibited from transferring or using their shares as collateral without committee approval [19][20]. Distribution of Benefits - Cash dividends received during the lock-up period will be retained within the ESOP and distributed proportionally after the lock-up ends [23][24]. - Upon the expiration of the ESOP, a final settlement will be conducted within 30 working days, distributing shares based on participants' holdings [24][26].
安科生物: 安徽安科生物工程(集团)股份有限公司第4期员工持股计划管理办法